Aurora Cannabis Acquires Remaining Stake in MedReleaf Australia (Indica Industries)

Aurora Cannabis Acquires Reliva LLC

May 28, 2020

Consumer Products

Aurora Cannabis Inc. completed the acquisition of Reliva, LLC, a leading U.S. hemp-derived CBD consumer brand, in a transaction valued at approximately US$40 million in Aurora common shares plus an earn-out of up to US$45 million. The deal gives Aurora immediate U.S. retail CBD scale and distribution (Reliva products are sold in over 20,000 stores) and aims to combine Aurora's product innovation and international footprint with Reliva's U.S. retail relationships to accelerate growth.

Curaleaf Holdings Acquires Northern Green Canada

March 19, 2024

Pharmaceuticals

Curaleaf Holdings, Inc. has signed a deal to acquire Northern Green Canada, an EU-GMP certified Canadian licensed cannabis producer, to secure high-quality indoor EU-GMP flower supply and bolster Curaleaf's European and Australasian expansion. The acquisition is expected to close in Q2 2024 pending regulatory approvals and will strengthen Curaleaf's supply chain for key markets including Germany, Australia/New Zealand and the U.K.

Curaleaf Holdings Acquires Minority Stake in Curaleaf International

July 2, 2025

Consumer Products

Curaleaf Holdings, Inc. completed the buyout of a single strategic institutional investor's equity stake in Curaleaf International Holdings Limited, bringing Curaleaf's ownership of its European holding company to 100%. The transaction was settled in Curaleaf subordinate voting shares and is intended to strengthen control and accelerate the company's strategic initiatives and expansion across European markets.

Tilray Acquires Aphria to Create New Tilray (Business Combination)

May 3, 2021

Consumer Products

Tilray and Aphria completed their previously announced business combination, with Aphria shareholders receiving 0.8381 Tilray shares for each Aphria common share. The combined company will operate as Tilray, creating a global cannabis consumer packaged goods leader with expanded geographic footprint, product portfolio and targeted annual pre-tax cost synergies of approximately US$81 million.

Curaleaf Acquires Bloom Dispensaries

December 28, 2021

Consumer Products

Curaleaf Holdings, Inc. agreed to acquire Bloom Dispensaries, a vertically integrated single-state cannabis operator in Arizona, in an all-cash transaction valued at approximately US$211 million. The deal adds four retail dispensaries (Phoenix, Tucson, Peoria, Sedona) plus ~63,500 sq. ft. of adjacent cultivation and processing space in north Phoenix; Curaleaf will pay $51 million cash at close and the remainder via three promissory notes, and Bloom generated estimated 2021 revenue of ~$66 million with EBITDA margins above 40%.

Elixinol Acquires 25% Stake in Pet Releaf

April 24, 2019

Consumer Products

Elixinol purchased a 25% equity stake in Altmeds LLC, the maker of the Pet Releaf hemp‑derived CBD pet product line, to strengthen supply arrangements and provide growth capital to scale the business. The investment will fund working capital, new product lines and expansion of a new 25,000 sq. ft. production facility; Elixinol’s president will join the Pet Releaf board.